ArticleJournal of translational medicine2026
Enhancer-mediated DDIT4 activation by SMYD2-dependent H3K4me1 promotes pazopanib resistance in clear cell renal cell carcinoma.
Yun Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.